FDA panel unanimously backs expanding use of Amarin's heart drug Vascepa

A panel of experts to the U.S. FDA recommended allowing Amarin Corp Plc's fish-oil derived drug to be used as an add-on therapy for reducing the chance of heart attacks and strokes in high-risk patients with cardiovascular disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news